Therefore, our comprehensive analyses indicated that CASP4 is closely associated with cellular pyroptosis, immunotherapy, and drug treatment of gliomas, suggesting the potential of CASP4 as a novel therapeutic target in gliomas. The gene discussed is CASP4; the disease is central nervous system cancer.